StockData
Veracyte, Inc. logo

Veracyte, Inc. (VCYT) shareholders

VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3029% below fair value
$25.57+1.34 (+5.53%)

Close on Nov 18, 2026Market cap $2.06BP/E 18.3Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
89M of 80M shares
Institutional holders
370
80 new, 41 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 50 sales
Net sold $19.25M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.11,930,01815.20%13G (passive) amendmentJul 31, 2025
Artisan Investments GP LLC
Joint filing with Artisan Partners Asset Management Inc. (9.40%), Artisan Partners Holdings LP (9.40%) and 1 more
7,370,4679.40%13G (passive) amendmentSep 30, 2025
FMR LLC
Joint filing with Abigail P. Johnson (8.60%)
6,735,6978.60%13G (passive) amendmentSep 30, 2025
Artisan Partners Limited Partnership
Joint filing with Artisan Partners Asset Management Inc. (8.10%), Artisan Partners Holdings LP (8.10%) and 1 more
6,321,7758.10%13G (passive) amendmentJun 30, 2025
Abigail P. Johnson
Joint filing with FMR LLC (7.70%)
6,172,9967.70%13G (passive) amendmentSep 30, 2026
Artisan Partners Asset Management Inc.
Joint filing with Artisan Partners Holdings LP (6.90%), Artisan Investments GP LLC (6.90%) and 1 more
5,496,3706.90%13G (passive) amendmentMar 31, 2026
State Street Corporation5,043,5906.30%13G (passive)Mar 31, 2026
Vanguard Portfolio Management4,512,8525.67%13G (passive)Mar 31, 2026
Vanguard Capital Management4,132,2245.20%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of VCYTValueChange% of portfolio
BlackRock, Inc.13,486,43716.78%$792.06M+313,8190.01%
FMR LLC7,702,7469.58%$452.38M−61,1030.02%
Artisan Partners Limited Partnership5,538,4046.89%$325.27M+42,0340.52%
Vanguard Portfolio Management LLC4,716,1915.87%$276.98M+271,4610.01%
State Street Corp4,698,1285.84%$275.95M−345,4620.01%
Vanguard Capital Management LLC3,593,9224.47%$211.07M+61,6900.00%
Dimensional Fund Advisors LP2,826,5243.52%$166.01M−54,5660.03%
First Trust Advisors LP2,507,9023.12%$147.29M+390,8560.09%
ARK Investment Management LLC2,295,9512.86%$134.84M−757,8670.88%
Wellington Management Group Llp2,274,1602.83%$133.56M−284,1250.02%
Geode Capital Management, LLC2,104,0002.62%$123.59M+146,9040.01%
Goldman Sachs Group Inc1,642,9112.04%$96.49M+366,6510.01%
Fuller & Thaler Asset Management, Inc.1,509,7491.88%$88.67M+95,3870.24%
William Blair Investment Management, LLC1,431,5961.78%$84.08M+441,9090.25%
GW&K Investment Management, LLC1,416,5431.76%$83.19M−20,7790.65%
Morgan Stanley1,191,7901.48%$69.99M+393,9880.00%
Bank Of America Corp /De/1,102,2791.37%$64.74M−346,6180.00%
Driehaus Capital Management LLC1,045,8261.30%$61.42MNew0.36%
Northern Trust Corp996,1541.24%$58.50M+66,6540.01%
Charles Schwab Investment Management Inc939,9831.17%$55.21M+16,4100.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202637089M100.0%80 / 128122 / 419M8M
Q1 202633488M100.0%48 / 142102 / 3718M8M
Q4 202532988M100.0%65 / 108115 / 288M10M
Q3 202529890M100.0%70 / 9590 / 4617M12M
Q2 202527885M100.0%36 / 102103 / 4310M9M
Q1 202528785M100.0%27 / 112107 / 5612M8M
Q4 202431882M100.0%54 / 105121 / 2511M11M
Q3 202429382M100.0%77 / 8791 / 2219M11M
Q2 202424083M100.0%26 / 9085 / 297M7M
Q1 202424683M100.0%35 / 11866 / 379M4M
Q4 202325078M97.0%35 / 80105 / 205M4M
Q3 202323677M95.3%28 / 9779 / 205M5M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

345 funds held VCYT in Q2 2026, 54% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of VCYTValue% of fundAs of
iShares Core S&P Small-Cap ETF4,807,2455.98%$282.33M0.25%Jun 30, 2026
Vanguard Total Stock Market Index Fund2,532,1103.15%$148.71M0.01%Jun 30, 2026
First Trust NYSE Arca Biotechnology Index Fund2,441,1853.04%$143.37M5.10%Jun 30, 2026
iShares Russell 2000 ETF2,079,9192.59%$122.15M0.15%Jun 30, 2026
Vanguard Small-Cap Index Fund1,830,6422.28%$107.51M0.06%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF1,496,4641.86%$87.89M0.82%Jun 30, 2026
Select Health Care Portfolio1,280,0001.59%$59.32M1.03%May 31, 2026
Artisan Mid Cap Fund1,236,1331.54%$72.60M2.27%Jun 30, 2026
Vanguard Small-Cap Growth Index Fund1,053,8871.31%$61.89M0.13%Jun 30, 2026
ARK Innovation ETF1,026,0151.28%$47.53M0.85%Jul 31, 2026
Select Medical Technology and Devices Portfolio1,000,0001.24%$46.34M1.56%May 31, 2026
Vanguard Explorer Fund983,8161.22%$45.57M0.21%Jul 31, 2026
Fullerthaler Behavioral Small-Cap Growth977,5001.22%$57.41M0.93%Jun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund956,7731.19%$56.19M0.50%Jun 30, 2026
Vanguard Extended Market Index Fund915,0411.14%$53.74M0.06%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Marc StapleyChief Executive Officer, Director432,0730.54%Sep 4, 2026
Jonathan WygantVP, Chief Accounting Officer41,9200.05%Oct 29, 2026
John LeiteGlobal Chief Commercial Off124,3290.15%Sep 22, 2026
Phillip G. FebboChief Scientific & Med Officer133,0480.17%Sep 4, 2026
Rebecca ChambersChief Financial Officer167,2000.21%Sep 4, 2026
Annie McGuireEVP, General Counsel132,2600.16%Sep 4, 2026
Kevin Richard HaasChief Dev and Tech Officer44,2210.06%Apr 14, 2026
Jens HolsteinDirector27,4710.03%Oct 28, 2026
Karin EasthamDirector11,4880.01%Oct 28, 2026
Muna BhanjiDirector40,8540.05%Oct 20, 2026
Robert S. EpsteinDirector57,7180.07%Jun 15, 2026
Evan/ Fa JonesDirector34,6340.04%Jun 15, 2026
David Brent ShaferDirector31,1000.04%Jun 15, 2026
Eliav BarrDirector56,4610.07%Jun 15, 2026
Thomas F. MillerDirector31,1000.04%Jun 15, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Jonathan Wygant
VP, Chief Accounting Officer
Oct 28, 2026Tax withholding−1,306$50.31$65.70K41,920
Jens Holstein
Director
Oct 27, 2026Sale(10b5-1 plan)−7,500$50.00$375.00K27,471
Jens Holstein
Director
Oct 27, 2026Option exercise+7,500$35.30$264.75K34,971
Karin Eastham
Director
Oct 27, 2026Sale(10b5-1 plan)−14,850$50.00$742.57K10,247
Karin Eastham
Director
Oct 27, 2026Option exercise+10,000$27.01$270.10K25,097
Muna Bhanji
Director
Oct 19, 2026Sale(10b5-1 plan)−1,864$43.70$81.46K40,854
Jens Holstein
Director
Sep 24, 2026Sale(10b5-1 plan)−7,500$47.00$352.50K27,471
Jens Holstein
Director
Sep 24, 2026Option exercise+7,500$35.30$264.75K34,971
John Leite
Global Chief Commercial Off
Sep 21, 2026Sale(10b5-1 plan)−4,015$40.00$160.60K124,329
Jens Holstein
Director
Sep 14, 2026Sale(10b5-1 plan)−5,000$40.95$204.75K27,471
Phillip G. Febbo
Chief Scientific & Med Officer
Sep 4, 2026Sale(10b5-1 plan)−2,705$43.66$118.10K133,048
Phillip G. Febbo
Chief Scientific & Med Officer
Sep 4, 2026Sale(10b5-1 plan)−10,405$42.89$446.27K135,753
Annie McGuire
EVP, General Counsel
Sep 4, 2026Sale(10b5-1 plan)−2,154$42.79$92.17K132,260
Annie McGuire
EVP, General Counsel
Sep 4, 2026Sale(10b5-1 plan)−1,100$43.67$48.04K131,160
Rebecca Chambers
Chief Financial Officer
Sep 4, 2026Sale(10b5-1 plan)−2,477$42.81$106.04K167,200
Rebecca Chambers
Chief Financial Officer
Sep 4, 2026Sale(10b5-1 plan)−1,175$43.71$51.36K166,025
Phillip G. Febbo
Chief Scientific & Med Officer
Sep 2, 2026Tax withholding−3,639$44.88$163.32K146,158
John Leite
Global Chief Commercial Off
Sep 2, 2026Tax withholding−3,961$44.88$177.77K128,344
Annie McGuire
EVP, General Counsel
Sep 2, 2026Tax withholding−3,215$44.88$144.29K134,414
Rebecca Chambers
Chief Financial Officer
Sep 2, 2026Tax withholding−3,603$44.88$161.70K169,677
Marc Stapley
Chief Executive Officer, Director
Sep 2, 2026Tax withholding−8,782$44.88$394.14K432,073
Jonathan Wygant
VP, Chief Accounting Officer
Sep 2, 2026Tax withholding−1,361$44.88$61.08K43,226
Muna Bhanji
Director
Sep 1, 2026Sale(10b5-1 plan)−1,864$42.97$80.10K42,718
Karin Eastham
Director
Jun 18, 2026Sale(10b5-1 plan)−529$53.55$28.33K15,097
Karin Eastham
Director
Jun 18, 2026Sale(10b5-1 plan)−3,200$52.78$168.90K15,626
Jens Holstein
Director
Jun 11, 2026Award+5,272––32,471
Karin Eastham
Director
Jun 11, 2026Award+5,272––18,826
Evan/ Fa Jones
Director
Jun 11, 2026Award+5,272––34,634
Thomas F. Miller
Director
Jun 11, 2026Award+5,272––31,100
Robert S. Epstein
Director
Jun 11, 2026Award+5,272––57,718
Eliav Barr
Director
Jun 11, 2026Award+5,272––56,461
Muna Bhanji
Director
Jun 11, 2026Award+5,272––44,582
David Brent Shafer
Director
Jun 11, 2026Award+5,272––31,100
John Leite
Global Chief Commercial Off
Jun 4, 2026Sale(10b5-1 plan)−13,975$50.07$699.73K132,305
Rebecca Chambers
Chief Financial Officer
Jun 4, 2026Sale(10b5-1 plan)−1,961$50.09$98.23K173,280
Rebecca Chambers
Chief Financial Officer
Jun 4, 2026Sale(10b5-1 plan)−1,600$49.28$78.85K175,241
Marc Stapley
Chief Executive Officer, Director
Jun 4, 2026Sale(10b5-1 plan)−138,051$50.12$6.92M440,494
Marc Stapley
Chief Executive Officer, Director
Jun 4, 2026Option exercise+138,051$36.60$5.05M578,545
Annie McGuire
EVP, General Counsel
Jun 4, 2026Sale(10b5-1 plan)−1,400$49.31$69.03K139,016
Annie McGuire
EVP, General Counsel
Jun 4, 2026Sale(10b5-1 plan)−1,776$50.12$89.01K137,240
John Leite
Global Chief Commercial Off
Jun 2, 2026Tax withholding−4,059$47.80$194.02K146,280
Rebecca Chambers
Chief Financial Officer
Jun 2, 2026Tax withholding−3,693$47.80$176.53K176,841
Phillip G. Febbo
Chief Scientific & Med Officer
Jun 2, 2026Tax withholding−3,730$47.80$178.29K149,797
Jonathan Wygant
VP, Chief Accounting Officer
Jun 2, 2026Tax withholding−1,361$47.80$65.06K44,073
Marc Stapley
Chief Executive Officer, Director
Jun 2, 2026Tax withholding−9,012$47.80$430.77K440,494
Annie McGuire
EVP, General Counsel
Jun 2, 2026Tax withholding−3,292$47.80$157.36K140,416
Jonathan Wygant
VP, Chief Accounting Officer
May 22, 2026Sale−24,000$45.40$1.09M45,434
Jonathan Wygant
VP, Chief Accounting Officer
May 22, 2026Option exercise+24,000$24.80$595.20K69,434
Robert S. Epstein
Director
May 20, 2026Sale(10b5-1 plan)−10,000$44.01$440.10K52,446
Annie McGuire
SVP, General Counsel
May 6, 2026Sale(10b5-1 plan)−5,102$40.00$204.08K143,708
Annie McGuire
SVP, General Counsel
May 6, 2026Sale(10b5-1 plan)−5,102$38.05$194.13K148,810
Kevin Richard Haas
Chief Dev and Tech Officer
Apr 10, 2026Award+44,221––44,221
Rebecca Chambers
Chief Financial Officer
Mar 6, 2026Award+13,157––180,534
Rebecca Chambers
Chief Financial Officer
Mar 6, 2026Award+36,181––167,377
Annie McGuire
SVP, General Counsel
Mar 6, 2026Award+26,314––153,912
Annie McGuire
SVP, General Counsel
Mar 6, 2026Award+32,892––127,598
Marc Stapley
Chief Executive Officer, Director
Mar 6, 2026Award+92,099––449,653
Jonathan Wygant
VP, Chief Accounting Officer
Mar 6, 2026Award+10,525––45,434
Phillip G. Febbo
Chief Scientific & Med Officer
Mar 6, 2026Award+29,603––146,949
Phillip G. Febbo
Chief Scientific & Med Officer
Mar 6, 2026Award+6,578––153,527

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
12.10%
10M shares short
Days to cover
8.2
At 1M shares a day
Change since last report
-2.7%
From 10M shares
Short volume, 20 days
37.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Veracyte's stock actually held short. Settlement fails (shares not delivered on time) peaked at 23,770 shares on Sep 18, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Karin Eastham
Director
Oct 27, 202614,850$715.77KOct 27, 2026Exercise of Stock Options
Jens Holstein
Director
Oct 27, 20267,500$375.00KOct 27, 2026Stock Option Exercise
Jens Holstein
Director
Sep 24, 20267,500$352.50KSep 24, 2026Stock Option Exercise
John Leite
Officer
Sep 21, 20264,015$159.78KSep 21, 2026Restricted Stock Units
Jens Holstein
Director
Sep 14, 20265,000$204.75KSep 14, 2026Restricted Stock
Ann McGuire
Officer
Sep 4, 20263,254$145.36KSep 4, 2026Restricted Stock Units
Phillip G. Febbo
Officer
Sep 4, 202613,110$585.62KSep 4, 2026Restricted Stock Units
Rebecca Chambers
Officer
Sep 4, 20263,652$163.13KSep 4, 2026Restricted Stock Units
Muna Bhanji
Director
Sep 1, 20263,728$161.01KSep 1, 2026Restricted Stock Units
Karin Eastham
Director
Jun 18, 20263,729$191.26KJun 18, 2026Restricted Stock Units
Ann McGuire
Officer
Jun 4, 20263,176$154.64KJun 4, 2026Restricted Stock Units
John Leite
Officer
Jun 4, 202613,975$680.44KJun 4, 2026Restricted Stock Units
Marc Stapley
Director, Officer
Jun 4, 2026138,051$6.72MJun 4, 2026Exercise of Stock Options
Rebecca Chambers
Officer
Jun 4, 20263,561$173.39KJun 4, 2026Restricted Stock Units
Robert S. Epstein
Director
May 20, 202610,000$416.90KMay 20, 2026Previously Exercised Stock Options

Congress trades

14 trades in Veracyte reported by 3 members of the House

MemberTypeTradedAmountFiled
Gilbert Cisneros
CA31
BoughtMar 3, 2026$1K–15KApr 7, 2026
Gilbert Cisneros
CA31
Sold (part)Nov 12, 2025$1K–15KDec 15, 2025
Gilbert Cisneros
CA31
BoughtJun 16, 2025$1K–15KJul 10, 2025
Josh Gottheimer
NJ05 · joint account
BoughtOct 16, 2023$1K–15KNov 11, 2023
Josh Gottheimer
NJ05 · joint account
Sold (part)Sep 15, 2023$1K–15KOct 15, 2023
Daniel Goldman
NY10
Sold (part)Apr 10, 2023$1K–15KMay 19, 2023
Gilbert Cisneros
CA31
Sold (part)Dec 23, 2020$1K–15KJan 11, 2021
Gilbert Cisneros
CA31
Sold (part)Dec 10, 2020$1K–15KJan 11, 2021
Josh Gottheimer
NJ05 · joint account
Sold (part)Dec 8, 2020$1K–15KJan 7, 2021
Gilbert Cisneros
CA31
Sold (part)Oct 29, 2020$1K–15KNov 5, 2020
Gilbert Cisneros
CA31
BoughtJan 17, 2020$1K–15KFeb 18, 2020
Gilbert Cisneros
CA31
BoughtDec 24, 2019$1K–15KJan 10, 2020
Gilbert Cisneros
CA31
BoughtDec 12, 2019$1K–15KJan 10, 2020
Josh Gottheimer
NJ05 · joint account
BoughtDec 6, 2019$1K–15KJan 6, 2020

See a number that looks wrong?